SMN1 and proximal spinal muscular atrophy: Typically involving DNA extraction from dried blood spot (DBS) samples, followed by real‐time quantitative polymerase chain reaction (qPCR) to ascertain homozygous exon 7 deletion of SMN1 gene (>95% of SMA cases), these programs represent a significant step forward.16